Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
FRP Holdings
FRPH
$449M
| $2.15M | ﹤0.01% |
98,325
-3,324
| -3% | -$77.3K |
|
2702
National CineMedia
NCMI
$354M
| $2.14M | ﹤0.01% |
701,260
-12,608
| -2% | -$44.3K |
|
2703
Xperi
XPER
$365M
| $2.13M | ﹤0.01% |
380,476
-13,160
| -3% | -$76.2K |
|
2704
NWPX Infrastructure Inc
NWPX
$1.25B
| $2.13M | ﹤0.01% |
27,331
-207
| -0.8% | -$14.9K |
|
2705
Editas Medicine
EDIT
$399M
| $2.13M | ﹤0.01% |
861,326
+66,655
| +8% | +$141K |
|
2706
Genius Sports
GENI
$1.73B
| $2.12M | ﹤0.01% |
478,749
-64,244
| -12% | -$457K |
|
2707
Evolus
EOLS
$394M
| $2.12M | ﹤0.01% |
515,516
-1,613
| -0.3% | -$7.82K |
|
2708
Organogenesis Holdings
ORGO
$308M
| $2.09M | ﹤0.01% |
879,832
+173,133
| +24% | +$600K |
|
2709
Talkspace
TALK
$873M
| $2.08M | ﹤0.01% |
402,467
-44,162
| -10% | -$195K |
|
2710
Diageo
DEO
$46.2B
| $2.08M | ﹤0.01% |
27,893
-26,434
| -49% | -$2.31M |
|
2711
The RMR Group
RMR
$342M
| $2.08M | ﹤0.01% |
134,174
-3,450
| -3% | -$56K |
|
|
SNBR
2712
DELISTED
Sleep Number
SNBR
| $2.07M | ﹤0.01% |
1,154,388
+33,143
| +3% | +$249K |
|
|
AMBQ
2713
Ambiq Micro
AMBQ
$1.7B
| $2.06M | ﹤0.01% |
81,067
+47,234
| +140% | +$1.41M |
|
2714
Eve Holding
EVEX
$798M
| $2.05M | ﹤0.01% |
828,223
+17,556
| +2% | +$59.9K |
|
2715
Lexicon Pharmaceuticals
LXRX
$1.02B
| $2.05M | ﹤0.01% |
1,311,298
+256,175
| +24% | +$373K |
|
2716
Ginkgo Bioworks
DNA
$481M
| $2.04M | ﹤0.01% |
332,394
-25,901
| -7% | -$215K |
|
2717
Farmers National Banc Corp
FMNB
$899M
| $2.03M | ﹤0.01% |
154,634
+48,987
| +46% | +$643K |
|
2718
SELLAS Life Sciences
SLS
$2.23B
| $2.03M | ﹤0.01% |
480,604
+72,203
| +18% | +$323K |
|
2719
FLEX LNG
FLNG
$1.67B
| $2.03M | ﹤0.01% |
68,422
-9,667
| -12% | -$267K |
|
|
IMSR
2720
Terrestrial Energy
IMSR
$517M
| $2.03M | ﹤0.01% |
337,991
-72,886
| -18% | -$578K |
|
|
GBFH
2721
GBank Financial Holdings
GBFH
$449M
| $2.01M | ﹤0.01% |
75,000
-2,158
| -3% | -$66.2K |
|
2722
Burford Capital
BUR
$907M
| $2M | ﹤0.01% |
442,121
-58,308
| -12% | -$510K |
|
2723
Stellantis
STLA
$16.5B
| $1.99M | ﹤0.01% |
281,146
-900
| -0.3% | -$7.54K |
|
2724
Keros Therapeutics
KROS
$199M
| $1.99M | ﹤0.01% |
179,952
-6,827
| -4% | -$105K |
|
|
NAGE
2725
Niagen Bioscience
NAGE
$256M
| $1.97M | ﹤0.01% |
447,359
-12,086
| -3% | -$65.3K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.